772 results on '"Collen, Désiré"'
Search Results
202. 3.P.118 Oxidation of LDL, endothelial injury and coronary artery disease
203. Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis
204. A mouse model for Zellweger syndrome
205. Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator–Deficient and Plasminogen Activator Inhibitor-1–Overexpressing Mice
206. Nonisotopic Quantitative Analysis of Protein–DNA Interactions at Equilibrium
207. Epitope mapping by negative selection of randomized antigen libraries displayed on filamentous phage 1 1Edited by J. Karn
208. Role of the Arg123–Tyr166 Paired Helix of Apolipoprotein A-I in Lecithin:Cholesterol Acyltransferase Activation
209. 145 Use of adenoviral vectors to increase reverse cholesterol transport
210. 2 The oxidation hypothesis of atherosclerosis
211. Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System
212. Staphylokinase Requires NH2-terminal Proteolysis for Plasminogen Activation
213. Identification of a Multihormone Responsive Enhancer Far Upstream from the Human Tissue-type Plasminogen Activator Gene
214. Thrombolytic Therapy
215. Gene Manipulation and Transfer of the Plasminogen and Coagulation System in Mice
216. Pluripotential rabbit embryonic stem (ES) cells are capable of forming overt coat color chimeras following injection into blastocysts
217. Characterization of the murine plasminogen/urokinase‐type plasminogen‐activator system
218. Role of tissue factor in embryonic blood vessel development
219. Effects of Deletion of the Carboxyl-terminal Domain of ApoA-I or of Its Substitution with Helices of ApoA-II on in Vitro and in Vivo Lipoprotein Association
220. Characterization of a Helicase-Like Transcription Factor Involved in the Expression of the Human Plasminogen Activator Inhibitor-1 Gene
221. Comparative Antigenicity of Recombinant Wild-Type Staphylokinase (SakSTAR) and a Selected Mutant (SakSTAR.M38) in a Baboon Thrombolysis Model
222. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
223. Comparative Effects of Staphylokinase and Alteplase in Rabbit Bleeding Time Models
224. Fibrin-Selective Thrombolytic Therapy With Recombinant Staphylokinase
225. Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure
226. Functional Significance of NH2- and COOH-Terminal Regions of Staphylokinase in Plasminogen Activation
227. Genetic Analysis Of The Plasminogen And Coagulation System In Mice
228. Effects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice
229. Structure-Function Relationships in Staphylokinase as Revealed by "Clustered Charge to Alanine" Mutagenesis
230. A Randomized Trial of Recombinant Staphylokinase Versus Alteplase for Coronary Artery Patency in Acute Myocardial Infarction
231. Thrombolytic Therapy of Peripheral Arterial Occlusion With Recombinant Staphylokinase
232. Lipid Lowering and Enhancement of Fibrinolysis With Niacin
233. Gene targeting and gene transfer studies of the plaeminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis
234. Generation of Monoclonal Antibodies against Autologous Proteins in Gene-inactivated Mice
235. Antithrombotic Effects of Thrombolytic Agents in a Platelet-Rich Femoral Vein Thrombosis Model in the Hamster
236. Retinoic Acid Induction of Human Tissue-type Plasminogen Activator Gene Expression via a Direct Repeat Element (DR5) Located at −7 Kilobases
237. Biological Effects of Combined Inactivation of Plasminogen Activator and Plasminogen Activator Inhibitor-1 Gene Function in Mice
238. Differential Inhibition with Antifibrinolytic Agents of Staphylokinase and Streptokinase Induced Clot Lysis
239. Gene Targeting and Gene Transfer Studies of the Biological Role of the Plasminogen/Plasmin System
240. Immunoassay of Murine t-PA, u-PA and PAI-1 Using Monoclonal Antibodies Raised in Gene-inactivated Mice
241. Oxidized lipoproteins in atherosclerosis and thrombosis
242. Is there an optimal thrombolytic regimen?
243. Physiological consequences of loss of plasminogen activator gene function in mice
244. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26
245. High Yield Production and Purification of Recombinant Staphylokinase for Thrombolytic Therapy
246. On the Immunogenicity of Recombinant Staphylokinase in Patients and in Animal Models
247. Comparative Thrombolytic Properties of Tissue-Type Plasminogen Activator and of a Plasminogen Activator Inhibitor-1 -Resistant Glycosylation Variant, in a Combined Arterial and Venous Thrombosis Model in the Dog
248. Antithrombotic Effects and Bleeding Time Prolongation with Synthetic Platelet GPIIb/llla Inhibitors in Animal Models of Platelet-Mediated Thrombosis
249. On the future of thrombolytic therapy for acute myocardial infarction
250. Coronary thrombolysis with K1K2PU, a chimeric tissue-type and urokinase-type plasminogen activator
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.